المؤلفون: Satoh, T, Ledesma, DA, Yoshihara, N

المصدر: In Value in Health October-November 2017 20(9):A446-A446

المؤلفون: Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Li-Ning-Tapia E; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hudgens C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Gu J; School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX., Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Casavilca-Zambrano S; Department of Pathology, Instituto Nacional de Enfermedades Neoplasicas (INEN), Lima, and Facultad de Ciencias de la Salud, Universidad de Huánuco, Huánuco, Peru (SCZ)., Castillo M; Department of Pathology, Instituto Nacional de Enfermedades Neoplasicas (INEN), Lima, and Facultad de Ciencias de la Salud, Universidad de Huánuco, Huánuco, Peru (SCZ)., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Giubellino A; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN; and., Curry JL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Torres-Cabala C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

المصدر: The American Journal of dermatopathology [Am J Dermatopathol] 2024 Jul 01; Vol. 46 (7), pp. 410-415. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7911005 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-0311 (Electronic) Linking ISSN: 01931091 NLM ISO Abbreviation: Am J Dermatopathol Subsets: MEDLINE

مواضيع طبية MeSH: Skin Neoplasms*/pathology , Skin Neoplasms*/genetics , Skin Neoplasms*/metabolism , Melanoma*/pathology , Melanoma*/genetics , Melanoma*/metabolism , Proto-Oncogene Proteins c-bcl-2*/metabolism , Bcl-2-Like Protein 11*/metabolism , Bcl-2-Like Protein 11*/genetics , Myeloid Cell Leukemia Sequence 1 Protein*/metabolism , Myeloid Cell Leukemia Sequence 1 Protein*/genetics , Apoptosis* , Biomarkers, Tumor*/metabolism , Biomarkers, Tumor*/analysis, Humans ; Male ; Female ; Middle Aged ; Aged ; Proto-Oncogene Proteins B-raf/genetics ; Adult ; Immunohistochemistry ; Aged, 80 and over

المؤلفون: Akakura K; JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan., Uemura H; Yokohama City University Medical Center, Yokohama, Japan., Kawakami S; Saitama Medical Center, Saitama Medical University, Saitama, Japan., Yokomizo A; Harasanshin Hospital, Fukuoka, Japan., Nakamura M; NHO Kyushu Cancer Center, Fukuoka, Japan., Nishimura K; Osaka International Cancer Institute, Osaka, Japan., Komori T; Bayer Yakuhin, Ltd, Osaka, Japan., Ledesma DA; Bayer Yakuhin, Ltd, Osaka, Japan.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Apr; Vol. 20 (12), pp. 781-798. Date of Electronic Publication: 2024 Jan 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/radiotherapy , Radium*/adverse effects , Bone Neoplasms*/radiotherapy, Male ; Humans ; Japan/epidemiology ; Quality of Life

المؤلفون: Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Navarrete J; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lazcano RN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Alani A; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Huen A; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Duvic M; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nagarajan P; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Aung PP; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Curry JL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Miranda RN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Torres-Cabala CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

المصدر: Cells [Cells] 2024 Feb 27; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Skin Neoplasms*/pathology , Mycosis Fungoides*/pathology, Humans ; Nuclear Receptor Subfamily 1, Group F, Member 3 ; B7-H1 Antigen/metabolism ; Up-Regulation ; Programmed Cell Death 1 Receptor/metabolism ; Glia Maturation Factor/metabolism ; Forkhead Transcription Factors/metabolism

المؤلفون: Ledesma DA; Market Access Oncology Bayer Yakuhin, Ltd., Tokyo, Japan., Chua JL; IQVIA Asia Pacific Singapore, Real World Insights, Singapore., Tang SSH; IQVIA Asia Pacific Singapore, Real World Insights, Singapore., Lim XW; IQVIA Asia Pacific Singapore, Real World Insights, Singapore.

المصدر: Journal of health economics and outcomes research [J Health Econ Outcomes Res] 2023 Oct 31; Vol. 10 (2), pp. 91-99. Date of Electronic Publication: 2023 Oct 31 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Columbia Data Analytics, LLC Country of Publication: United States NLM ID: 101648581 Publication Model: eCollection Cited Medium: Internet ISSN: 2327-2236 (Electronic) Linking ISSN: 2326697X NLM ISO Abbreviation: J Health Econ Outcomes Res Subsets: PubMed not MEDLINE

المؤلفون: Sanchez JI; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jiao J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Solis Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Saldarriaga OA; Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA., Stevenson HL; Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555, USA., Beretta L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

المصدر: Cancers [Cancers (Basel)] 2023 May 23; Vol. 15 (11). Date of Electronic Publication: 2023 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Zhou Y; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Medik YB; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel B; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Zamler DB; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Chen S; Ministry of Education Key Lab of Bioinformatics and Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing, China., Chapman T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Schneider S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX., Park EM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Babcock RL; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Chrisikos TT; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Kahn LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Dyevoich AM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Pineda JE; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Wong MC; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX., Mishra AK; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX., Cass SH; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Cogdill AP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX., Johnson DH; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Johnson SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wadud Khan MA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Peterson CB; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Joon AY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Peng W; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Li HS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tang X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Raso MG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Zhang X; Ministry of Education Key Lab of Bioinformatics and Bioinformatics Division, Beijing National Research Center for Information Science and Technology; Department of Automation, Tsinghua University, Beijing, China., Foo WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Tetzlaff MT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Diehl GE; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Clise-Dwyer K; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX., Whitley EM; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX., Gubin MM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Hwu P; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX.; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX.; Platform for Innovative Microbiome and Translational Research, MD Anderson Cancer Center, Houston, TX.

المصدر: The Journal of experimental medicine [J Exp Med] 2023 Feb 06; Vol. 220 (2). Date of Electronic Publication: 2022 Nov 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

مواضيع طبية MeSH: Interleukin-6* , Colitis*/pathology, Mice ; Animals ; Quality of Life ; Immunotherapy ; Inflammation

المؤلفون: Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan., Shiota M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan., Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan., Satoh T; Satoh Takefumi Prostate Clinic, Tokyo, Japan., Stroupe A; Open Health, Newton, Massachusetts, USA., Seo C; Open Health, Newton, Massachusetts, USA., Uzumcu A; Open Health, Newton, Massachusetts, USA., Ledesma DA; Market Access Oncology, Bayer Yakuhin, Ltd., Tokyo, Japan.

المصدر: Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (2), pp. 1762-1778. Date of Electronic Publication: 2022 Jun 30.

نوع المنشور: Review; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/pathology, Male ; Humans ; Quality of Life ; East Asian People ; Treatment Outcome ; Pain

المؤلفون: Seervai RNH; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.; Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA., Cho WC; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chu EY; Department of Dermatology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ledesma DA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Richards K; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Heberton MM; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nagarajan P; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Prieto VG; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Curry JL; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Journal of cutaneous pathology [J Cutan Pathol] 2022 Jan; Vol. 49 (1), pp. 61-81. Date of Electronic Publication: 2021 Oct 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0425124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0560 (Electronic) Linking ISSN: 03036987 NLM ISO Abbreviation: J Cutan Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/therapeutic use , Drug Eruptions*/metabolism , Drug Eruptions*/pathology , Enzyme Inhibitors*/adverse effects , Enzyme Inhibitors*/therapeutic use , Neoplasms*/drug therapy , Neoplasms*/metabolism , Neoplasms*/pathology, Humans

المؤلفون: Akakura K; Department of Urology, Japan Community Health Care Organization (JCHO) Tokyo Shinjuku Medical Center, 5-1 Tsukudo-cho, Shinjuku, 162-8543, Japan., Uemura H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan., Miyazaki K; School of Public Health, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan., Stroupe A; Patient-Centered Outcomes, Open Health, Newton, MA 02458, USA., Seo C; Patient-Centered Outcomes, Open Health, Bethesda, MD 20814, USA., Uzumcu A; Patient-Centered Outcomes, Open Health, Newton, MA 02458, USA., Ledesma DA; Market Access Oncology, Bayer Yakuhin, Ltd, Marunouchi 1-6-5, Chiyoda-ku, Tokyo, 100-8265, Japan.

المصدر: Future oncology (London, England) [Future Oncol] 2021 Dec; Vol. 17 (36), pp. 5103-5118. Date of Electronic Publication: 2021 Oct 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Bone Neoplasms/*diagnosis , Bone Neoplasms/*radiotherapy , Prostatic Neoplasms, Castration-Resistant/*diagnosis , Prostatic Neoplasms, Castration-Resistant/*radiotherapy, Aged ; Aged, 80 and over ; Bone Neoplasms/psychology ; Bone Neoplasms/secondary ; Cost of Illness ; Decision Making ; Humans ; Interviews as Topic ; Japan ; Male ; Middle Aged ; Physicians ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/psychology ; Qualitative Research ; Quality of Life ; Radium/therapeutic use